Patrick O'Neil to Humans
This is a "connection" page, showing publications Patrick O'Neil has written about Humans.
Connection Strength
0.658
-
Long-term maintenance of weight loss. Lancet Public Health. 2022 10; 7(10):e806-e807.
Score: 0.032
-
Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life. Transl Behav Med. 2021 12 14; 11(12):2091-2098.
Score: 0.031
-
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
Score: 0.027
-
Evaluation of a Lifestyle Change Worksite Weight Management Program Across Multiple Employers and Sites. J Occup Environ Med. 2018 12; 60(12):1112-1115.
Score: 0.025
-
Body Weight Considerations in the Management of Type 2 Diabetes. Adv Ther. 2019 01; 36(1):44-58.
Score: 0.025
-
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.
Score: 0.024
-
Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention. Obesity (Silver Spring). 2017 12; 25(12):2062-2067.
Score: 0.023
-
Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials. Diabetes Obes Metab. 2017 11; 19(11):1529-1536.
Score: 0.023
-
Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
Score: 0.022
-
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
Score: 0.021
-
Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
Score: 0.021
-
EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS. Endocr Pract. 2016 11; 22(11):1277-1287.
Score: 0.021
-
A novel approach to training students in delivering evidence-based obesity treatment. Fam Med. 2015 May; 47(5):378-82.
Score: 0.019
-
Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
Score: 0.017
-
Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
Score: 0.017
-
Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eat Behav. 2012 Dec; 13(4):354-60.
Score: 0.016
-
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012 Jul; 20(7):1426-36.
Score: 0.016
-
Socially desirable responding by bariatric surgery candidates during psychological assessment. Surg Obes Relat Dis. 2013 Mar-Apr; 9(2):300-5.
Score: 0.015
-
Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond). 2009 Jan; 33(1):144-50.
Score: 0.012
-
Clinical practice as natural laboratory for psychotherapy research: a guide to case-based time-series analysis. Am Psychol. 2008 Feb-Mar; 63(2):77-95.
Score: 0.012
-
Editorial: lessons from, and on, the psychological assessment of bariatric surgery patients. Surg Obes Relat Dis. 2006 Mar-Apr; 2(2):133-5.
Score: 0.010
-
Weighing the evidence: benefits of regular weight monitoring for weight control. J Nutr Educ Behav. 2005 Nov-Dec; 37(6):319-22.
Score: 0.010
-
Utility and validity of the eating behavior inventory in clinical obesity research: a review of the literature. Obes Rev. 2005 Aug; 6(3):209-16.
Score: 0.010
-
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol. 2004 Mar; 9(1):59-65.
Score: 0.009
-
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res. 2002 Jul; 10(7):633-41.
Score: 0.008
-
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.
Score: 0.008
-
Assessing dietary intake in the management of obesity. Obes Res. 2001 Dec; 9 Suppl 5:361S-366S; discussion 373S-374S.
Score: 0.008
-
Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2021 11 02; 10(21):e022930.
Score: 0.008
-
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 04 13; 325(14):1403-1413.
Score: 0.007
-
Which comes first in the pathogenesis of bulimia nervosa: dieting or bingeing? Int J Eat Disord. 2000 Nov; 28(3):259-64.
Score: 0.007
-
The perceived relative worth of reaching and maintaining goal weight. Int J Obes Relat Metab Disord. 2000 Aug; 24(8):1069-76.
Score: 0.007
-
Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019 08 08; 381(6):520-530.
Score: 0.006
-
Description, utilisation and results from a telehealth primary care weight management intervention for adults with obesity in South Carolina. J Telemed Telecare. 2020 Jan-Feb; 26(1-2):28-35.
Score: 0.006
-
The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
Score: 0.006
-
Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care. 2018 08; 41(8):1590-1599.
Score: 0.006
-
Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study. Obesity (Silver Spring). 2018 01; 26(1):61-69.
Score: 0.006
-
The National Women's Study: relationship of victimization and posttraumatic stress disorder to bulimia nervosa. Int J Eat Disord. 1997 Apr; 21(3):213-28.
Score: 0.006
-
Effects of body fat distribution on body size estimation accuracy among obese women. Int J Obes Relat Metab Disord. 1997 Mar; 21(3):250-3.
Score: 0.005
-
Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.
Score: 0.005
-
The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016 09; 40(9):1369-75.
Score: 0.005
-
The number of divergent purging behaviors is associated with histories of trauma, PTSD, and comorbidity in a national sample of women. Eat Disord. 2015; 23(5):422-9.
Score: 0.005
-
Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes. Obesity (Silver Spring). 2014 Oct; 22(10):2137-46.
Score: 0.005
-
A comparison of women with child-adolescent versus adult onset binge eating: results from the National Women's Study. Int J Eat Disord. 2014 Nov; 47(7):836-43.
Score: 0.005
-
Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013 Nov; 21(11):2189-2196.
Score: 0.004
-
Factors associated with development of excessive fatness in children and adolescents: a review of prospective studies. Obes Rev. 2013 Aug; 14(8):645-58.
Score: 0.004
-
Pharmacotherapy of obesity: clinical treatments and considerations. Am J Med Sci. 2013 Apr; 345(4):284-288.
Score: 0.004
-
The Food Craving Questionnaire-Trait in a bariatric surgery seeking population and ability to predict post-surgery weight loss at six months. Eat Behav. 2012 Dec; 13(4):366-70.
Score: 0.004
-
Psychological aspects of obesity and very-low-calorie diets. Am J Clin Nutr. 1992 07; 56(1 Suppl):185S-189S.
Score: 0.004
-
Prefrontal cortex transcranial direct current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite. 2011 Jun; 56(3):741-6.
Score: 0.004
-
Seasonal patterns of birth for subjects with bulimia nervosa, binge eating, and purging: results from the National Women's Study. Int J Eat Disord. 2012 Jan; 45(1):131-4.
Score: 0.004
-
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
Score: 0.003
-
Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring). 2009 Jan; 17(1):30-9.
Score: 0.003
-
The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008 Sep; 51(2):324-6.
Score: 0.003
-
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity (Silver Spring). 2007 Apr; 15(4):895-905.
Score: 0.003
-
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance. Am J Drug Alcohol Abuse. 2007; 33(5):655-64.
Score: 0.003
-
Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite. 2007 Mar; 48(2):145-53.
Score: 0.003
-
Changes in food cravings during low-calorie and very-low-calorie diets. Obesity (Silver Spring). 2006 Jan; 14(1):115-21.
Score: 0.003
-
Findings and outcomes of psychological evaluations of gastric bypass applicants. Surg Obes Relat Dis. 2005 Nov-Dec; 1(6):523-7; discussion 528-9.
Score: 0.002
-
Smoking status and weight loss in three weight loss programs. Eat Behav. 2006 Jan; 7(1):61-8.
Score: 0.002
-
Gender, race, and obesity-related quality of life at extreme levels of obesity. Obes Res. 2004 Jun; 12(6):949-55.
Score: 0.002
-
Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
Score: 0.002
-
Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
Score: 0.002
-
A prospective study of holiday weight gain. N Engl J Med. 2000 Mar 23; 342(12):861-7.
Score: 0.002
-
Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
Score: 0.002
-
Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
Score: 0.002
-
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 1999 Jun; 69(6):1108-16.
Score: 0.002
-
Cognitive appraisals of dietary transgressions by obese women: associations with self-reported eating behavior, depression, and actual weight loss. Int J Obes Relat Metab Disord. 1999 Mar; 23(3):231-7.
Score: 0.002
-
Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation. Addict Behav. 1979; 4(2):167-77.
Score: 0.002
-
Clinical trial design for obesity agents: a workshop report. Obes Res. 1998 Jul; 6(4):311-5.
Score: 0.002
-
Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 1997 Dec; 67(3):272-6.
Score: 0.001
-
Prevalence of binge eating disorder in obese adults seeking weight loss treatment. Eat Weight Disord. 1997 Sep; 2(3):117-24.
Score: 0.001
-
Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr. 1995 Nov; 127(5):741-4.
Score: 0.001
-
Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
Score: 0.001
-
Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8.
Score: 0.001
-
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry. 1990 Feb; 147(2):225-9.
Score: 0.001
-
Depression and bulimia: the link between depression and bulimic cognitions. J Abnorm Psychol. 1989 Aug; 98(3):322-5.
Score: 0.001
-
Update on the management of obesity. South Med J. 1988 May; 81(5):632-9.
Score: 0.001
-
Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(6):893-8.
Score: 0.001
-
Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
Score: 0.001
-
A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
Score: 0.001
-
Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
Score: 0.000
-
Taste hedonics and thresholds in obesity. Int J Obes. 1980; 4(3):203-12.
Score: 0.000